TrialESMO open2025

Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients.

A Gravina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.